Antares Pharma Escapes Fraud Suit Over Drug Statements
By Bill Wichert ( July 2, 2019, 4:40 PM EDT) -- A New Jersey federal judge on Tuesday nixed a proposed securities class action against Antares Pharma Inc. after finding that a shareholder failed to back up his claims that the company made false and misleading statements about a testosterone medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.